This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n16http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216224%3A14110%2F09%3A00036397%21RIV10-MSM-14110___/
dctermshttp://purl.org/dc/terms/
n17http://localhost/temp/predkladatel/
n18http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n14http://linked.opendata.cz/ontology/domain/vavai/
n12http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n6http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n9http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216224%3A14110%2F09%3A00036397%21RIV10-MSM-14110___
rdf:type
n14:Vysledek skos:Concept
dcterms:description
%22Poor prognosis%22 NSCLC patients were treated with erlotinib and their survival of evaluated. Erlotinib therapy in non small cell lung cancer patients-survival of %22poor prognosis patients%22 %22Poor prognosis%22 NSCLC patients were treated with erlotinib and their survival of evaluated. Erlotinib therapy in non small cell lung cancer patients-survival of %22poor prognosis patients%22
dcterms:title
Erlotinib therapy in non small cell lung cancer patients-survival of %22poor prognosis patients%22 Erlotinib therapy in non small cell lung cancer patients-survival of %22poor prognosis patients%22
skos:prefLabel
Erlotinib therapy in non small cell lung cancer patients-survival of %22poor prognosis patients%22 Erlotinib therapy in non small cell lung cancer patients-survival of %22poor prognosis patients%22
skos:notation
RIV/00216224:14110/09:00036397!RIV10-MSM-14110___
n3:aktivita
n8:Z
n3:aktivity
Z(MSM 141100003)
n3:cisloPeriodika
9
n3:dodaniDat
n9:2010
n3:domaciTvurceVysledku
n18:1559729 n18:2428245
n3:druhVysledku
n13:J
n3:duvernostUdaju
n6:S
n3:entitaPredkladatele
n16:predkladatel
n3:idSjednocenehoVysledku
313496
n3:idVysledku
RIV/00216224:14110/09:00036397
n3:jazykVysledku
n15:eng
n3:klicovaSlova
non small cell lung cancer; erlotinib; treatment of %22poor prognosis%22 patients
n3:klicoveSlovo
n7:non%20small%20cell%20lung%20cancer n7:erlotinib n7:treatment%20of%20%2522poor%20prognosis%2522%20patients
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[BB435C1EF79F]
n3:nazevZdroje
Journal of Thoracic Oncology
n3:obor
n10:FC
n3:pocetDomacichTvurcuVysledku
2
n3:pocetTvurcuVysledku
12
n3:rokUplatneniVysledku
n9:2009
n3:svazekPeriodika
4
n3:tvurceVysledku
Vyzula, Rostislav Dimka, Sixtová Petruželka, Luboš Skřičková, Jana Kolek, Vítězslav Pavlík, Tomáš Zatloukal, Petr Krejčí, Jana Roubec, Jaromír Koubková, Leona Salajka, Vítězslav Pešek, Miloš
n3:zamer
n12:MSM%20141100003
s:issn
1556-0864
s:numberOfPages
3
n17:organizacniJednotka
14110